StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.37−0.37 (-2.09%)

Close on Nov 18, 2026Market cap $474.25MP/E –Yield –

Carlsmed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Carlsmed's revenue for the twelve months ending Jun 30, 2026 was $63.30M, up 65.4% year over year. For fiscal 2025 it was $50.51M, up 85.9% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$50.51M+85.9%
FY2024Dec 31, 2024$27.17M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$18.94M+56.7%
Q1 FY2026Mar 31, 2026$16.12M+58.2%
Q4 FY2025Dec 31, 2025$15.17M+61.2%
Q3 FY2025Sep 30, 2025$13.07M+98.4%
Q2 FY2025Jun 30, 2025$12.08M+98.7%
Q1 FY2025Mar 31, 2025$10.19M–
Q4 FY2024Dec 31, 2024$9.41M–
Q3 FY2024Sep 30, 2024$6.59M–
Q2 FY2024Jun 30, 2024$6.08M–

More Carlsmed figures

See a number that looks wrong?